Bruker Q4 Revenues Decline 8 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Bruker reported after the close of the market on Thursday that its fourth quarter revenues declined 8 percent year over year as currency effects negatively impacted revenues by more than 6 percent. 

For the three months ended Dec. 31, 2014, the company reported revenues of $508 million, down from $552.1 million in Q4 2013. The results were short of the average analysts' estimate of $515.5 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.